Clinical data, regulatory milestones, AI-assisted discovery platforms, and expanding development pipelines are creating a steady stream of catalysts that investors will be watching closely during the ...

Although the potential transformative effect of electronic health record (EHR) data on clinical research in adult patient populations has been very extensively discussed, the effect on pediatric ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. By 2020, U.S. healthcare data had reached 2,314 exabytes—15 times more than in 2013—thanks ...

The integration of artificial intelligence (AI) and machine learning (ML) in oncology clinical trials is rapidly evolving alongside the broader field. For example, AI-driven adaptive trial designs may ...

In the late 1800s, the U.S. railroad system didn’t just revolutionize transportation—it catalyzed entirely new industries. Refrigerated railcars enabled a national meatpacking economy. Standard time ...

NEW YORK--(BUSINESS WIRE)--Datavant, the leading health data platform company, today announced the launch of the Datavant Clinical Insights Platform, an integrated offering that empowers health plans ...

Early data suggest KLN-1010, now acquired by Eli Lilly, could be more tolerable but less efficacious that AstraZeneca’s ESOT-01.

Ocugen’s model fair value holds at US$11.43 per share, with no change to the underlying price target despite fresh clinical ...

– All myositis patients in the Phase 1/2 DM/ASyS cohort with sufficient follow-up who met key registrational inclusion criteria exceeded the registrational primary endpoint, demonstrating major TIS ...